Thomas Lass Klitgaard

MD, PhD, Department of Anaesthesia and Intensive Care Aalborg University Hospital, Denmark. Coordinating investigator #HOTICU

[Thomas Lass Klitgaard @TLKlitgaard]

@DogICUma @MegaROXtrial Absolutely an interesting population to investigate further. Much potential for treatment improvement

[Thomas Lass Klitgaard @TLKlitgaard]

Newest insights from the HOT-ICU trial

[British Journal of Anaesthesia @BJAJournals]

New from #bjaopen Lower versus higher oxygenation targets in ICU patients with haematological malignancy — insights from the HOT-ICU trial #criticalcare #openaccess

https://t.co/OHj0Pva5kZ

[Thomas Lass Klitgaard @TLKlitgaard]

@SineWichmann @ARanberg @ESICM @CRIC_Int_Care @SUHhospital @ole_mathiesen @AndersPerner @MusaeusPoulsen Stort tillykke med det kæmpe arbejde!!!

[Thomas Lass Klitgaard @TLKlitgaard]

@yourICM @Dr_Cit @otavio_ranzani @GicoBellani @andymoz78 @JABERSamir3 @avkwong @nialldferguson @msh_manu @FOAMecmo @MarcLeone8 Important but very difficult question to answer!

[Thomas Lass Klitgaard @TLKlitgaard]

@ChrStaehr Financial conditions to continue research are definitively difficult to achieve! Most likely primary obstacle

[Thomas Lass Klitgaard @TLKlitgaard]

@DogICUma @MegaROXtrial Congratulations!

[Thomas Lass Klitgaard @TLKlitgaard]

@BodilSRasmussen presenting the long-term outcomes of the #HOTICU trial in Belfast #CCR22 #LONGHOTtrial @CRIC_Int_Care
Quality of life & mortality (https://t.co/6xtIRzZclJ) + new data on long-term pulmonary and cognitive function after #ICU admission for respiratory failure.

[Thomas Lass Klitgaard @TLKlitgaard]

@DogICUma @MegaROXtrial Great work! Looking very much forward to the results.

[Thomas Lass Klitgaard @TLKlitgaard]

@BodilSRasmussen Thank you @BodilSRasmussen and @OlavSchj for your fantastic support and excellent teamwork!

[Intensive Care Medicine @yourICM]

Lower (8 kPa) vs higher oxygenation (12 kPa) targets: no longterm survival benefit nor HRQoL improvement at 1y in #ICU pts with severe hypoxaemia (HOT-ICU trial cohort). Substantial impairments in several EQ-5D-5L dimensions in survivors in both groups.
🖇️ https://t.co/P48Cd5sIWK

[Thomas Lass Klitgaard @TLKlitgaard]

@nickmmark @CritCareReviews Yes, we are very excited to present the results of the LONG-HOT trial @BodilSRasmussen @CRIC_Int_Care #HOT_ICU

[Thomas Lass Klitgaard @TLKlitgaard]

@AndersPerner @LVS_Videnskab Deltager i mødet!

[Thomas Lass Klitgaard @TLKlitgaard]

@bharathkumartv @yourICM @AndersPerner Great study. Congratulations with completion.

[Camilla Bekker @BekkerCamilla]

World Delirium Day 16/3 2022
Focus On delirium. #AIDICU TRIAL soon finish recruitment!@CRIC_Int_Care @MusaeusPoulsen @ARanberg @ole_mathiesen @AndersPerner @BekkerCamilla and a new association In Denmark #danishdeliriumassociation

[Critical Care Reviews @CritCareReviews]

The one year outcomes of the HOT-ICU trial will be presented at #CCR22 by @BodilSRasmussen
What effect will lower or higher oxygenation targets have on longer term functional outcomes like cognition?
Join us in June to find out!
https://t.co/7rX7fNoTnQ

[Thomas Lass Klitgaard @TLKlitgaard]

@CritCareReviews @nuttchristopher @bronwenconnolly @BasaltGroup @EmmaMacSweeney @MyIntensiveCare @ICS_updates @ESICM @SCCM @anzicsctg @ICSIreland Absolutely a fantastic resource!

[Thomas Lass Klitgaard @TLKlitgaard]

@DogICUma @fabio_taccone Excellent talk! Absolutely agree. Looking much forward to results from MEGA-ROX

[Thomas Lass Klitgaard @TLKlitgaard]

@JohannesGrand @CritCareReviews Looking much forward to the results. Congratulations to the BOX trial team!

[British Journal of Anaesthesia @BJAJournals]

Bayesian analysis #HOTICU, large mortality-effects unlikely, potential higher mortality with low O2-target and high norepinephrine doses
@BJAJournals @TLKlitgaard @andersgranholm @ICU_Management @ESICM

https://t.co/bbfkjAr6pq

[Thomas Lass Klitgaard @TLKlitgaard]

Potential benefit of higher oxygenation strategy in patients with shock #HOTICU @BJAJournals https://t.co/UJ5gbKalbz